NCT05621486View on ClinicalTrials.gov

A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid Tumors

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 14, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2026

Conditions
Advanced Solid Tumor
Interventions
BIOLOGICAL

B4T2-001 Autologous CAR T cells

Each subject will receive infusion with B4T2-001 autologous CAR T Cells

Trial Locations (2)

200126

Shanghai East Hospital, Shanghai

200131

Shanghai Artemed Hospital, Shanghai

All Listed Sponsors
collaborator

Bio4T2 LLC

INDUSTRY

lead

Shanghai East Hospital

OTHER